Guangxi Changzhou Natural Pharmaceutical

Guangxi Changzhou Natural Pharmaceutical is a leading Chinese high-tech enterprise specializing in the research, development, and large-scale production of natural plant extracts. Founded in 1994 and headquartered in Nanning, the company is a global leader in Centella asiatica (Gotu Kola) derivatives, supplying over 70% of the Chinese market's raw materials. Its core product portfolio includes high-purity pharmaceutical and cosmetic ingredients such as Asiaticoside, Madecassoside, and Titrated Extract of Centella Asiatica (TECA). The company also manufactures finished traditional Chinese medicine products, most notably Xishangle Tincture for the treatment of trauma and bruises. Operating from advanced GMP-certified facilities, it serves the pharmaceutical, skincare, and nutraceutical sectors across Asia, Europe, and North America. It supports its global operations through an innovation hub in Guangzhou and a dedicated European business unit in France.